Validation of a simplified provocation instrument for diagnosis and threshold testing of symptomatic dermographism
- PMID: 25522055
- DOI: 10.1111/ced.12547
Validation of a simplified provocation instrument for diagnosis and threshold testing of symptomatic dermographism
Abstract
Background: Symptomatic dermographism is a common urticarial condition, which requires determination of provocation thresholds to confirm diagnosis and allow physicians to individualize management and therapy for optimal control of symptoms. To determine provocation thresholds, we have developed a provocation test device, the FricTest(®) 4.0. This simple and inexpensive device, which is stroked across the skin to produce a response, consists of a flat plastic comb with four round-ended plastic pins, 3 mm in diameter, and of differing lengths.
Aim: To validate the FricTest(®) 4.0 by comparison with FricTest 3.0 in determining provocation thresholds in symptomatic dermographism,
Methods: Dermal provocation with the FricTest 4.0 and FricTest 3.0 was performed in parallel on the volar forearm of 30 patients with symptomatic dermographism and 30 healthy controls. The widths of the resulting weals were measured, and weals with a width of ≥ 3 mm were considered positive. Accompanying pruritus was assessed using a 10-point verbal rating scale.
Results: All 30 patients with symptomatic dermographism, but none of the healthy volunteers, showed positive responses to provocation with the strongest trigger strength, showing that FricTest(®) 4.0 has 100% sensitivity and specificity for diagnosing symptomatic dermographism. Quantitatively, both devices were similar in the number of patients who responded positively to different pin lengths. Results for pruritus were also similar with both instruments.
Conclusions: The FricTest 4.0 is a simple and inexpensive instrument for determining provocation thresholds in patients with symptomatic dermographism. It should find a place in both routine clinical investigation and in therapeutic trials.
© 2014 British Association of Dermatologists.
Similar articles
-
A novel, simple, validated and reproducible instrument for assessing provocation threshold levels in patients with symptomatic dermographism.Clin Exp Dermatol. 2013 Jun;38(4):360-6; quiz 366. doi: 10.1111/ced.12107. Clin Exp Dermatol. 2013. PMID: 23621090
-
Food-dependent and food-exacerbated symptomatic dermographism: New variants of symptomatic dermographism.J Allergy Clin Immunol. 2022 Feb;149(2):788-790. doi: 10.1016/j.jaci.2021.07.030. Epub 2021 Aug 8. J Allergy Clin Immunol. 2022. PMID: 34375619
-
Eating Increases and Exercise Decreases Disease Activity in Patients With Symptomatic Dermographism.J Allergy Clin Immunol Pract. 2023 Mar;11(3):932-940. doi: 10.1016/j.jaip.2022.11.041. Epub 2022 Dec 16. J Allergy Clin Immunol Pract. 2023. PMID: 36535522
-
Shedding light on dermographism: a narrative review.Int J Dermatol. 2024 Aug;63(8):999-1006. doi: 10.1111/ijd.17102. Epub 2024 Feb 28. Int J Dermatol. 2024. PMID: 38419351 Review.
-
Physical urticarias and cholinergic urticaria.Immunol Allergy Clin North Am. 2014 Feb;34(1):73-88. doi: 10.1016/j.iac.2013.09.010. Epub 2013 Oct 28. Immunol Allergy Clin North Am. 2014. PMID: 24262690 Review.
Cited by
-
The relationship of Fric test responses with an urticaria activity score, urticaria control test and quality of life scales in patients with symptomatic dermographism.An Bras Dermatol. 2025 Jul 7;100(5):501147. doi: 10.1016/j.abd.2025.501147. Online ahead of print. An Bras Dermatol. 2025. PMID: 40628000 Free PMC article.
-
Assessing the reliability of the FricTest® 4.0 for diagnosing symptomatic dermographism.Clin Transl Allergy. 2024 Nov;14(11):e70005. doi: 10.1002/clt2.70005. Clin Transl Allergy. 2024. PMID: 39537400 Free PMC article. No abstract available.
-
Feasibility and Utility of the Fric Test in Symptomatic Dermographism: A Pilot Study.Indian J Dermatol. 2015 Nov-Dec;60(6):638. doi: 10.4103/0019-5154.169167. Indian J Dermatol. 2015. PMID: 26677310 Free PMC article. No abstract available.
-
The Classification, Pathogenesis, Diagnostic Workup, and Management of Urticaria: An Update.Handb Exp Pharmacol. 2022;268:117-133. doi: 10.1007/164_2021_506. Handb Exp Pharmacol. 2022. PMID: 34247278
-
IgE and high-affinity IgE receptor in chronic inducible urticaria, pathogenic, and management relevance.Clin Transl Allergy. 2022 Feb 1;12(2):e12117. doi: 10.1002/clt2.12117. eCollection 2022 Feb. Clin Transl Allergy. 2022. PMID: 35126995 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical